Test for ovarian, endometrial cancers

Could cells taken from a Pap test offer the first-ever early screening method?

Every year, nearly 70,000 women in the United States are diagnosed with ovarian and endometrial cancers, and about one-third of them die. Researchers at Johns Hopkins University have developed a test they say can detect ovarian and endometrial cancers from fluid taken during a routine Pap test. The new test—called PapGene—analyzes DNA from ovarian and endometrial cancer cells that have been shed into the cervical fluid.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »